These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16647558)

  • 1. Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia.
    Zaja F; Vianelli N; Battista M; Sperotto A; Patriarca F; Tomadini V; Filì C; Tani M; Baccarani M; Fanin R
    Exp Hematol; 2006 May; 34(5):571-2. PubMed ID: 16647558
    [No Abstract]   [Full Text] [Related]  

  • 2. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
    Zaja F; Battista ML; Pirrotta MT; Palmieri S; Montagna M; Vianelli N; Marin L; Cavallin M; Bocchia M; Defina M; Ippoliti M; Ferrara F; Patriarca F; Avanzini MA; Regazzi M; Baccarani M; Isola M; Soldano F; Fanin R
    Haematologica; 2008 Jun; 93(6):930-3. PubMed ID: 18403395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood.
    Taube T; Schmid H; Reinhard H; von Stackelberg A; Overberg US
    Haematologica; 2005 Feb; 90(2):281-3. PubMed ID: 15710595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.
    Santos ES; Arosemena LR; Raez LE; O'Brien C; Regev A
    Liver Int; 2006 Jun; 26(5):625-9. PubMed ID: 16762009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory autoimmune thrombocytopenic purpura treatment with Rituximab.
    Patel K; Berman J; Ferber A; Caro J
    Am J Hematol; 2001 May; 67(1):59-60. PubMed ID: 11279663
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab treatment for symptomatic chronic ITP.
    Tamminga RY; Bruin MC
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):714-6. PubMed ID: 16933264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory autoimmune thrombocytopenic purpura: responses to treatment with a recombinant antibody to lymphocyte membrane antigen CD20 (rituximab).
    Narang M; Penner JA; Williams D
    Am J Hematol; 2003 Dec; 74(4):263-7. PubMed ID: 14635207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
    Narat S; Gandla J; Hoffbrand AV; Hughes RG; Mehta AB
    Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
    Medeot M; Zaja F; Vianelli N; Battista M; Baccarani M; Patriarca F; Soldano F; Isola M; De Luca S; Fanin R
    Eur J Haematol; 2008 Sep; 81(3):165-9. PubMed ID: 18510702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab.
    Kuwana M; Iki S; Urabe A
    Am J Hematol; 2007 Sep; 82(9):846-8. PubMed ID: 17506067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
    Cooper N; Evangelista ML; Amadori S; Stasi R
    Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP).
    Alasfoor K; Alrasheed M; Alsayegh F; Mousa SA
    Ann Hematol; 2009 Mar; 88(3):239-43. PubMed ID: 18704420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus.
    ten Cate R; Smiers FJ; Bredius RG; Lankester AC; van Suijlekom-Smit LW; Huizinga TW; Egeler RM
    Rheumatology (Oxford); 2004 Feb; 43(2):244. PubMed ID: 14739467
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults.
    Provan D; Butler T; Evangelista ML; Amadori S; Newland AC; Stasi R
    Haematologica; 2007 Dec; 92(12):1695-8. PubMed ID: 18055995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura.
    Ojeda-Uribe M; Federici L; Wolf M; Coppo P; Veyradier A
    Transfusion; 2010 Mar; 50(3):733-5. PubMed ID: 20609201
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of refractory autoimmune thrombocytopenia with rituximab and cyclosporin A in a patient with chronic granulomatous disease.
    Treliński J; Chojnowski K; Kurenko-Deptuch M; Kasznicki M; Bernatowska E; Robak T
    Ann Hematol; 2005 Nov; 84(12):835-6. PubMed ID: 16078034
    [No Abstract]   [Full Text] [Related]  

  • 19. Critical issues of current and future developments in the treatment of immune thrombocytopenic purpura.
    Koene HR
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):703-5. PubMed ID: 16933273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidences for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy.
    Toffoletti E; Zaja F; Chiarvesio A; Michelutti A; Battista M; Fanin R
    Haematologica; 2008 May; 93(5):795-6. PubMed ID: 18450740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.